Compare BHP Billiton Limited (BHP) vs Novavax Inc (NVAX) Price & Performance

BHP trades at $90.36, down 0.28% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported mixed Q4 2025 earnings, missing EPS estimates, while Q2 2025 beat expectations. Revenue for 2024 was $55.66B with a net income margin of 18.97%, though profitability has fluctuated in recent years. Recent news highlights labor strikes at Port Hedland iron ore operations, potentially impacting production and revenue streams.

Outlook is cautious due to operational risks from strikes and volatile commodity prices, but strong cash flow and institutional buying support long-term value. Analysts are predominantly neutral with 65% hold ratings, reflecting balanced risk-reward. Key risks include labor disputes and copper output misses, while opportunities lie in AI-driven copper demand growth and cost management.

Novavax (NVAX) trades at $7.97, up 1.01% with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported strong Q2 2026 results, beating revenue and earnings estimates while raising full-year guidance. Despite negative profitability metrics, valuation ratios appear attractive with P/E of 3.14 and EV/EBITDA of 1.72. Recent news highlights progress with Sanofi partnership and cost reduction initiatives.

The outlook remains challenged by negative cash flows and accumulated deficits, but analyst sentiment is positive with 74% buy ratings. Key risks include ongoing operational losses and vaccine demand volatility, while potential upside exists from partnership milestones and adjuvant platform expansion. The stock presents a high-risk opportunity with significant analyst support despite fundamental weaknesses.